InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,083.26
(
-0.27%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: knuts4oe post# 30056

Wednesday, 01/22/2020 9:59:22 PM

Wednesday, January 22, 2020 9:59:22 PM

Post# of 30990
MYMD Pharmaceuticals needs to show that MYMD-1 can treat Hashimoto's Thyroiditis. That is their entryway to be "First IN Class" in this promising health breakthrough.

http://www.pharmatimes.com/news/roche_recruits_rheos_to_explore_immunometabolism_1320740
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up